Reflow Medical, 208 Avenida Fabricante, Ste. 100, San Clemente, CA (2026)

09/15/2026

Peripheral Artery Disease (PAD) can develop quietly, which means the warning signs are easy to overlook.
At its most advanced stage, Chronic Limb-Threatening Ischemia (CLTI) is associated with a 29% risk of death or major amputation within one year. Recognizing symptoms early can make a meaningful difference.

Signs to look out for include:
• Leg pain when walking
• Cramping in the hips, thighs, or calves during activity
• One foot or leg feeling colder than the other
• Numbness or weakness
• Changes in skin color or appearance
• Wounds that are slow to heal
• Slow-growing toenails or hair loss on the legs

If something does not feel right, do not wait for symptoms to get worse. Getting checked early and seeing a vascular specialist can help protect limbs and lives.

🔗 Learn more about PAD at The Way to My Heart: https://www.thewaytomyheart.org/

A special thank you to Kym McNicholas , Founder and CEO of the Global PAD Association, for her continued work to raise awareness and support people living with PAD through education, advocacy, and support.

09/11/2026

This week, DEEPER REVEAL crossed the Atlantic. Presented earlier this year in the U.S., the 12-month data returned to the stage at CIRSE 2026 in Copenhagen, this time shared by Kumar Madassery, MD, with the same sustained, encouraging outcomes in a challenging CLTI population.

Worth repeating: In patients with long, calcified BTK lesions, treatment with the Spur® Peripheral Retrievable Stent System following predilatation demonstrated clinical benefits above historical PTA outcomes at 12 months:

-Limb salvage: 94.6% vs. 89.4% historically
-Complete paired wound healing: 84.3% vs. 55.6% historically
-Freedom from clinically driven TLR: 83.1%* vs. 60–71% historically
-Primary patency by duplex ultrasound: 78.0%* vs. 28–64% historically

These findings highlight the potential of Retrievable Scaffold Therapy (RST) with Spur to provide durable outcomes while leaving nothing behind.

🔗 Learn more about Spur Stent System:
https://www.reflowmedical.com/spur/

🔗 Full U.S. Indications for Use and safety information:
https://www.reflowmedical.com/resources/

*At 12 months, vessel-related outcomes in appropriately selected vessels (core lab-measured reference vessel diameter ≥2.5 mm, per study protocol and indication for use) and patient-centered outcomes were assessed.

09/09/2026

What a response at .
Thank you to everyone who visited our booth, joined our sessions, and contributed to the clinical exchange in Copenhagen.

Special thanks to Maria Antonella Ruffino, MD, and Daniel van den Heuvel, MD, for leading our Peer-to-Peer Insight Sharing Sessions and discussing practical, case-based perspectives on complex endovascular interventions, including Spur® Retrievable Scaffold Therapy (RST) in BTK and CTO crossing with Wingman™.

We also thank Kumar Madassery, MD, for presenting the strong and sustained 12-month DEEPER REVEAL data and providing an important clinical update on Spur RST.

A few inspiring days of scientific exchange, real-world insights, and valuable discussions around advancing complex lesion treatment.

🔗 reflowmedical.com

09/07/2026

PAD is common. Yet it too often goes unrecognized.

When Peripheral Artery Disease progresses, it can lead to chronic limb threatening ischemia (CLTI), the most severe form of PAD, associated with a high risk of major amputation and mortality.

This is why awareness matters. Recognizing symptoms and risk factors earlier can support timely evaluation and access to appropriate vascular care.

Know the signs. Understand your risk. Ask questions. Take action.

Help raise awareness for PAD this month. Spread the word and join the Great Circulation Challenge by the Global PAD Association. Track your steps throughout the month and contribute them to help raise awareness for PAD.

Join the challenge:
https://padwalk.org/register.html

09/04/2026

Join us for two peer-to-peer insight sharing workshops at CIRSE 2026, where physicians share what's working in daily practice.

Gain actionable insights you can use to improve BTK CLTI treatment and simplify your approach to complex cases!

Real cases. Real strategies.

How Spur® RST is Changing the Way I Treat CLTI Patients, Daniel van den Heuvel, MD.
Sunday, September 6, 2026 | 10:30-11:30 | Room 66+67
Explore how retrievable scaffolds can advance BTK CLTI treatment through real-world cases, expert insights, and practical treatment algorithms.

👉 Register here: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=-oyYhHiaWkSL1WAzlptriq0iXi06WMVHup-CWDy2PotUQU83V1I4WE00UTgySk1aSEpPMFg1UUZWQi4u&origin=QRCode

Overcoming Complexities with Simple and Intuitive Tools, Maria Antonella Ruffino, MD.
Monday, September 7, 2026 | 10:30-11:30 | Room 66+67
Explore how simple and intuitive tools can simplify treatment algorithms, featuring real-world cases, expert insights, and practical techniques.

👉 Register here: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=-oyYhHiaWkSL1WAzlptriq0iXi06WMVHup-CWDy2PotUQVBaVkRPOTFETDJOTEs5V1pHWTBLTkRCSC4u&origin=QRCode

09/03/2026

Reflow Medical is heading to CIRSE 2026 in Copenhagen, where our program features oral presentations, peer-to-peer insight sharing, accepted poster abstracts spanning real-world case experience, and the latest DEEPER trial data in below-the-knee intervention.

Swipe through the carousel to explore the individual sessions, speakers, and abstracts in more detail.

Registration for our peer-to-peer insight sharing sessions is now open.

Join "How Spur RST Is Changing the Way I Treat CLTI Patients" here: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=-oyYhHiaWkSL1WAzlptriq0iXi06WMVHup-CWDy2PotUQU83V1I4WE00UTgySk1aSEpPMFg1UUZWQi4u&origin=QRCode

Or register for "Overcoming Complexities with Simple and Intuitive Tools" here: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=-oyYhHiaWkSL1WAzlptriq0iXi06WMVHup-CWDy2PotUQVBaVkRPOTFETDJOTEs5V1pHWTBLTkRCSC4u&origin=QRCode

Visit us at Booth D50 to continue the discussion and connect with the team on site.

We look forward to seeing you in Copenhagen, September 5-9!

09/01/2026

Great news for patient access to innovative BTK therapy in the United States.

We’re proud to share that CMS has approved a New Technology Add-on Payment (NTAP) for the FDA Breakthrough Device-designated Spur® Peripheral Retrievable Stent System, effective for discharges on or after October 1, 2026.

By recognizing the added costs of qualifying new technologies, NTAP may help hospitals address financial barriers to adoption and support timely access to Spur for Medicare beneficiaries.

For patients with infrapopliteal arterial disease, Spur provides temporary mechanical scaffolding and controlled lesion pe*******on as an adjunct to PTA. Following treatment, Spur is fully retrieved, leaving no permanent implant behind.

For more information on NTAP eligibility, coding, and payment:
https://www.reflowmedical.com/reimbursement/

Explore the revolutionary Spur® and review Important Safety Information:
https://www.reflowmedical.com/spur/

08/31/2026

Join the Great Circulation Challenge this September

In recognition of PAD Awareness Month, we're proud to support The Great Circulation Challenge, organized by the Global PAD Association, bringing people together through movement to raise awareness of Peripheral Artery Disease and vascular health.

Register for the challenge here: https://padwalk.org/register.html

Download the app.
Join the challenge.
Track your steps.
Help raise awareness for PAD.

From September 1 through 30, every contribution counts toward a collective goal of 60,000 miles, reflecting the approximately 60,000 miles of blood vessels in the human circulatory system.

Every walk, every mile and every participant helps bring greater visibility to
PAD and the importance of vascular health.

08/26/2026

Complex PCI can present different navigation and crossing challenges, requiring different catheter characteristics.

Cora Flex® combines a low profile with exceptional trackability and pushability to reach and cross the tightest lesions.

Cora Force® provides maximum tip force support for engaging heavily calcified and fibrotic lesions.

Both Cora Flex and Cora Force integrate our proprietary Cora Tech™ technology, which sets a new standard for coronary torqueable microcatheters.

Cora Tech enables highest bi-directional spinning freedom and best torque transmission compared to market leaders during navigation and crossing of complex coronary lesions.*

Two coronary torqueable microcatheters. Different designs for different lesion challenges. The same exceptional spinning freedom.

Learn more about Reflow Medical’s Cora Flex and Cora Force Torqueable Microcatheters:
https://www.reflowmedical.com/coracatheters/

For a complete listing of the Indications, Contraindications, Warnings, Precautions, Adverse Events, and Procedural Steps, please refer to the applicable Instructions for Use:
https://www.reflowmedical.com/resources/

08/24/2026

Long-Term Evidence for Spur® + PTX DCB in BTK Disease

Four-year outcomes from the DEEPER OUS study provide long-term insight into the durability of Spur® Retrievable Scaffold Therapy in conjunction with a paclitaxel-coated DCB in infrapopliteal lesions.

At 48 months:

96.6% freedom from major amputation
with no further major amputations observed between 36 and 48 months

84.5% freedom from CD-TLR
with no new CD-TLR cases after 24 months

Earlier outcomes further demonstrated 74.4% primary patency at 12 months
and a substantial reduction in patients with CLTI from 79.5% at baseline to 29.7% at 12 months, reflecting a clinically meaningful shift toward lower disease severity.

Together, these findings support the long-term durability of Spur® + PTX DCB, delivering strong long-term outcomes while leaving nothing behind.

Learn more about the 4-year DEEPER OUS data:
https://www.reflowmedical.com/wp-content/uploads/2026/08/DEEPER_OUS_Spur_PTX_DCB_MM0201_EU_Rev_A.pdf

For a complete listing of the Indications, Contraindications, Warnings, Precautions, Complications, and Directions for Use, please refer to the applicable U.S. and CE Instructions for Use (IFU):
https://www.reflowmedical.com/resources/

Reflow Medical

09/15/2026

09/11/2026

09/09/2026

09/07/2026

09/04/2026

09/03/2026

09/01/2026

08/31/2026

08/26/2026

08/24/2026

Address

Telephone

Website

Alerts

Contact The Business

Shortcuts

Share

Category

Listing takedown request